Outcomes of COVID-19 Infections in children: A single-center retrospective study

Basit Öğe Kaydı
dc.contributor.authorGenceli, Mustafa
dc.contributor.authorAkcan, Ozge Metin
dc.contributor.authorPekcan, Sevgi
dc.contributor.authorAkin, Fatih
dc.contributor.authorOzdemir, Mehmet
dc.contributor.authorKilic, Ahmet Osman
dc.contributor.authorYazar, Abdullah
dc.date.accessioned2024-02-23T13:03:31Z
dc.date.available2024-02-23T13:03:31Z
dc.date.issued2022
dc.departmentNEÜen_US
dc.description.abstractThe COVID-19 pandemic is an important cause of morbidity and mortality, which has had a negative impact worldwide. Our aim was to describe clinical findings and outcomes of severe acute respiratory syndrome (SARS)-CoV-2 viral infection and COVID-19 cared for at a large pediatric tertiary care hospital during the first year of the pandemic. Patients aged 1 month to 18 years who were diagnosed as having COVID-19 between March 2020 and April 2021 were included. The files of patients diagnosed with COVID-19 were reviewed retrospectively. Results: Four hundred sixty seven children were included in the study. There were 34 (7.3%) patients under 1 year of age, 111 (23.8%) between 1 and 5 years, 98 (30.4%) between 5 and 10 years, 142 (30.4%) between 11 and 15 years, and 82 (17.6%) age over 15 years. Fever (88.2%), vomiting (32.4%), and diarrhea (29.4%) in patients aged under 1 year, sore throat (36.6%) in patients aged 11-15 years, and dysgeusia (11%), anosmia (14.6%), headache (18.3%), malaise (40.8%), myalgia (28%), and shortness of breath (17.1%) in those aged over 15 years were found to be significantly more common in comparison with the other age groups (p < 0.05). Thirty-five (7.5%) patients were asymptomatic, 365 (78.1%) had mild disease, 35 (7.5%) were moderate, 27 (5.8%) were severe, and five (1.07%) were critical. Leukocyte count, erythrocyte sedimentation rate, ferritin, and C-reactive protein values were significantly higher in hospitalized patients. Three patients died during the study period (0.64%). While SARS-CoV-2 infection may be asymptomatic and COVID-19 usually has a mild clinical course, some children have severe disease or mortality.en_US
dc.identifier.doi10.1002/ppul.26070
dc.identifier.endpage2539en_US
dc.identifier.issn8755-6863
dc.identifier.issn1099-0496
dc.identifier.issue10en_US
dc.identifier.pmid35855567en_US
dc.identifier.scopus2-s2.0-85135243822en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage2533en_US
dc.identifier.urihttps://doi.org/10.1002/ppul.26070
dc.identifier.urihttps://hdl.handle.net/20.500.12452/10651
dc.identifier.volume57en_US
dc.identifier.wosWOS:000835293600001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofPediatric Pulmonologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectChildrenen_US
dc.subjectCovid-19en_US
dc.subjectPandemicen_US
dc.titleOutcomes of COVID-19 Infections in children: A single-center retrospective studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu